| Schedule of basic and diluted net income (loss) per ordinary share |
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per ordinary share: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | Year ended December 31, 2025 | | 2026 | | 2025 | | 2026 | | 2025 | | | Unaudited | | Unaudited | | Audited | | Net income (loss) attributable to ordinary shares as reported used in computing basic and diluted net income (loss) per share | $ | (10,435) | | | $ | (37,270) | | | $ | (97,231) | | | $ | (111,728) | | | $ | (136,227) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted average number of ordinary shares used in computing diluted net income (loss) per share | 116,785,198 | | | 111,908,252 | | | 115,685,559 | | | 111,259,532 | | | 111,471,991 | | | | | | | | | | | | Potentially anti-dilutive shares that were excluded from the computation of basic net income (loss) per share: | | | | | | | | | | | Options | 7,632,623 | | | 9,522,315 | | | 8,451,116 | | | 8,968,363 | | | 9,297,875 | | RSUs and PSUs | 5,157,532 | | | 4,995,367 | | | 4,332,798 | | | 4,828,118 | | | 4,781,731 | | | ESPP | 74,703 | | | 91,218 | | | 199,848 | | | 185,346 | | | 208,854 | | | Weighted anti-dilutive shares outstanding which were not included in the diluted calculation | 12,864,858 | | | 14,608,900 | | | 12,983,762 | | | 13,981,827 | | | 14,288,460 | | | | | | | | | | | | | Basic and diluted net income (loss) per ordinary share | $ | (0.09) | | | $ | (0.33) | | | $ | (0.84) | | | $ | (1.00) | | | $ | (1.22) | | | | | | | | | | | | | | | | | | | | | |
|